Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Hsu

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Virology|November 12, 2013
Evolutionarily conserved residues at an oligomerization interface of the influenza A virus neuraminidase are essential for viral survivalChee-Keng Mok, Guang-Wu Chen, Kuei-Chung Shih, et al.
Scientific Reports|September 28, 2017
Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strainsKai-Cheng Hsu, Hui-Chen Hung, Wei-Chun HuangFu, et al.
Chemmedchem|March 26, 2014
Facile identification of dual FLT3-Aurora A inhibitors: a computer-guided drug design approachYung Chang Hsu, Yi-Yu Ke, Hui-Yi Shiao, et al.
European Journal of Medicinal Chemistry|August 31, 2016
Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug designChun-Feng Chang, Wen-Hsing Lin, Yi-Yu Ke, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Inhibition of hepatitis C virus replication by arsenic trioxideDer-Ren Hwang, Yuan-Chin Tsai, Jin-Ching Lee, et al.
Antiviral Research|November 19, 2008
Aurintricarboxylic acid inhibits influenza virus neuraminidaseHui-Chen Hung, Ching-Ping Tseng, Jinn-Moon Yang, et al.
Analytical Chemistry|June 21, 2012
Development of an anti-influenza drug screening assay targeting nucleoproteins with tryptophan fluorescence quenchingHui-Chen Hung, Chia-Lin Liu, John T-A Hsu, et al.
Journal of Virology|February 21, 2014
Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycleShih-Hsin Chiu, Meng-Chuan Wu, Chung-Chun Wu, et al.
Bioorganic & Medicinal Chemistry|June 28, 2008
Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agentsChih-Jung Kuo, Jiun-Jie Shie, Jim-Min Fang, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Aurora kinase A inhibitors: identification, SAR exploration and molecular modeling of 6,7-dihydro-4H-pyrazolo-[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-dione scaffoldMohane Selvaraj Coumar, Jian-Sung Wu, Jiun-Shyang Leou, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Virology|November 12, 2013
Evolutionarily conserved residues at an oligomerization interface of the influenza A virus neuraminidase are essential for viral survivalChee-Keng Mok, Guang-Wu Chen, Kuei-Chung Shih, et al.
Scientific Reports|September 28, 2017
Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strainsKai-Cheng Hsu, Hui-Chen Hung, Wei-Chun HuangFu, et al.
Chemmedchem|March 26, 2014
Facile identification of dual FLT3-Aurora A inhibitors: a computer-guided drug design approachYung Chang Hsu, Yi-Yu Ke, Hui-Yi Shiao, et al.
European Journal of Medicinal Chemistry|August 31, 2016
Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug designChun-Feng Chang, Wen-Hsing Lin, Yi-Yu Ke, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Inhibition of hepatitis C virus replication by arsenic trioxideDer-Ren Hwang, Yuan-Chin Tsai, Jin-Ching Lee, et al.
Antiviral Research|November 19, 2008
Aurintricarboxylic acid inhibits influenza virus neuraminidaseHui-Chen Hung, Ching-Ping Tseng, Jinn-Moon Yang, et al.
Analytical Chemistry|June 21, 2012
Development of an anti-influenza drug screening assay targeting nucleoproteins with tryptophan fluorescence quenchingHui-Chen Hung, Chia-Lin Liu, John T-A Hsu, et al.
Journal of Virology|February 21, 2014
Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycleShih-Hsin Chiu, Meng-Chuan Wu, Chung-Chun Wu, et al.
Bioorganic & Medicinal Chemistry|June 28, 2008
Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agentsChih-Jung Kuo, Jiun-Jie Shie, Jim-Min Fang, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Aurora kinase A inhibitors: identification, SAR exploration and molecular modeling of 6,7-dihydro-4H-pyrazolo-[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-dione scaffoldMohane Selvaraj Coumar, Jian-Sung Wu, Jiun-Shyang Leou, et al.
Pageof 10